LTFS
PPH icon

Ladenburg Thalmann Financial Services’s VanEck Pharmaceutical ETF PPH Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$118K Sell
1,834
-117
-6% -$7.05K ﹤0.01% 2888
2019
Q3 		$111K Hold
1,951
– – ﹤0.01% 2859
2019
Q2 		$114K Sell
1,951
-175
-8% -$10.1K ﹤0.01% 2875
2019
Q1 		$129K Hold
2,126
– – ﹤0.01% 2723
2018
Q4 		$116K Buy
2,126
+117
+6% +$7.09K ﹤0.01% 2653
2018
Q3 		$129K Sell
2,009
-85
-4% -$5.3K ﹤0.01% 2643
2018
Q2 		$119K Hold
2,094
– – ﹤0.01% 2649
2018
Q1 		$119K Sell
2,094
-675
-24% -$40.3K ﹤0.01% 2649
2017
Q4 		$164K Sell
2,769
-630
-19% -$36.1K ﹤0.01% 2357
2017
Q3 		$196K Sell
3,399
-1,365
-29% -$77.5K ﹤0.01% 2124
2017
Q2 		$281K Sell
4,764
-1,671
-26% -$94.5K ﹤0.01% 1782
2017
Q1 		$355K Sell
6,435
-2,149
-25% -$117K ﹤0.01% 1519
2016
Q4 		$451K Sell
8,584
-574
-6% -$30.7K 0.01% 1322
2016
Q3 		$526K Buy
9,158
+1,027
+13% +$61.6K 0.01% 1167
2016
Q2 		$477K Buy
8,131
+2,805
+53% +$163K 0.01% 1158
2016
Q1 		$306K Buy
5,326
+3,150
+145% +$186K 0.01% 1328
2015
Q4 		$142K Hold
2,176
– – ﹤0.01% 1812
2015
Q3 		$137K Sell
2,176
-926
-30% -$65.1K ﹤0.01% 1758
2015
Q2 		$219K Sell
3,102
-2,757
-47% -$199K ﹤0.01% 1550
2015
Q1 		$412K Buy
5,859
+2,303
+65% +$156K 0.01% 1145
2014
Q4 		$229K Sell
3,556
-158
-4% -$10.1K 0.01% 1330
2014
Q3 		$236K Sell
3,714
-1,319
-26% -$81.7K 0.01% 1133
2014
Q2 		$312K Buy
5,033
+2,605
+107% +$155K 0.01% 982
2014
Q1 		$142K Buy
2,428
+1,691
+229% +$95.6K ﹤0.01% 1315
2013
Q4 		$39K Hold
737
– – ﹤0.01% 2093
2013
Q3 		$35K Buy
737
+337
+84% +$16K ﹤0.01% 2076
2013
Q2 		$18K Buy
+400
New +$18.5K ﹤0.01% 2410

Other funds holding PPH

CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Ladenburg Thalmann Financial Services's PPH Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its VanEck Pharmaceutical ETF (PPH) stake by 6% in Q4 2019, selling an estimated $7.05K and leaving 1,834 shares worth $118K. The position accounts for ﹤0.01% of the portfolio, ranked #2888.

Ladenburg Thalmann Financial Services first reported a position in PPH in Q2 2013 and has held it in 27 quarters since. The position peaked at $526K in Q3 2016. 49 funds tracked by Wall St. Rank hold PPH as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 1,834 shares of VanEck Pharmaceutical ETF worth $118K as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 117 VanEck Pharmaceutical ETF shares in Q4 2019, an estimated $7.05K.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #2888 holding.
  • Ladenburg Thalmann Financial Services first reported a position in VanEck Pharmaceutical ETF in Q2 2013 and has held it in 27 quarters since.
  • Ladenburg Thalmann Financial Services's VanEck Pharmaceutical ETF position peaked at $526K in Q3 2016.
  • 49 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.